Skip to content

Vivani Medical VANI Neurostimulation Division — Operating Lease Expense

Other segment segments

Biopharm Division
$1.13M+6.1%
Neuromodulation Division
$30K-72.7%

Similar metrics at other companies

Vor Biopharma logo
VOROperating Lease Expense
$109K-91.7%
Maze Therapeutics, Inc. Common Stock logo
MAZEOperating Lease Expense
$831K+8.3%
Surgery Partners, Inc. logo
SGRYLease expense
$23M+10.6%
Jade Biosciences, Inc. Common Stock logo
JBIOOperating Lease Expense
$26K+225%
FTC Solar logo
FTCILease Expense
$256K-21.7%
Fidelity National Financial logo
FNFOperating Lease Expense
$32M-3.0%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's neurostimulation division — operating lease expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's neurostimulation division — operating lease expense?
Vivani Medical (VANI) reported neurostimulation division — operating lease expense of $79.75K in Q4 2025.
What does neurostimulation division — operating lease expense mean?
Reflects the periodic costs associated with leasing facilities or equipment used specifically by the neurostimulation division. This expense represents the fixed overhead required to maintain the physical footprint necessary for the segment's operations. It is a key component of the division's recurring operational cost structure.